Finally, in cerebral ischemia, Smad1 may mainly function as a downstream effector of canonical BMP signaling, or alternatively, as a mediator of other stroke-induced signaling pathways, such as brain-derived neurotrophic factor (BDNF) or GSK3β signaling [38, 39]. Here, GSK3B is linked to brain ischemia.